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Haemophilus influenzae is able to use hemoglobin as a sole source of heme, and heme-repressible hemoglobin
binding to the cell surface has been demonstrated. Using an affinity purification methodology, a hemoglobin-
binding protein of approximately 120 kDa was isolated from H. influenzae type b strain HI689 grown in
heme-restricted but not in heme-replete conditions. The isolated protein was subjected to N-terminal amino
acid sequencing, and the derived amino acid sequence was used to design corresponding oligonucleotides. The
oligonucleotides were used to probe a Southern blot of EcoRI-digested HI689 genomic DNA. A hybridizing band
of approximately 4.2 kb was successfully cloned into pUC19. Using a 1.9-kb internal BglII fragment of the
4.2-kb clone as a probe, hybridization was seen in both typeable and nontypeable H. influenzae but not in other
bacterial species tested. Following partial nucleotide sequencing of the 4.2-kb insert, a putative open reading
frame was subcloned into an expression vector. The host Escherichia coli strain in which the cloned fragment
was expressed bound biotinylated human hemoglobin, whereas binding of hemoglobin was not detected in E.
coli with the vector alone. In conclusion, we hypothesize that the DNA fragment encoding an approximately
120-kDa heme-repressible hemoglobin-binding protein mediates one step in the acquisition of hemoglobin by
H. influenzae in vivo.
Haemophilus influenzae is responsible for many human in-
fections, including otitis media, meningitis, epiglottitis, and
pneumonia (52). The incidence of invasive disease caused by
strains with the type b capsule has been radically reduced
following the introduction of vaccines based on the type b
capsular polysaccharide (32, 37, 38, 43). However, vaccine fail-
ures occur, and although adults presumably have natural im-
munity, two thirds of H. influenzae blood isolates from adults
are type b (10, 24, 46). Since currently available vaccines are
based on the type b capsule, they provide no protection against
disease caused by unencapsulated strains of H. influenzae, and
such strains are a significant cause of otitis media in childhood,
of neonatal sepsis, and of pneumonia in adults (12, 51, 53, 54).
Viable vaccine candidates to provide protection against all H.
influenzae disease would include surface exposed proteins
which are widely distributed across the species and expressed
during disease.
H. influenzae has an absolute growth requirement for an
exogenous source of protoporphyrin IX, which is the immedi-
ate precursor of heme (11). In vivo, all heme is intracellular, in
the form of hemoglobin or heme-containing enzymes, and thus
unavailable to invading microorganisms (3, 18, 26). Hemoglo-
bin released by erythrocytes is avidly bound by the serum
protein haptoglobin, and the hemoglobin-haptoglobin complex
is rapidly cleared by hepatocytes (3, 40). Free heme, principally
derived from the degradation of methemoglobin, is bound by
the serum proteins hemopexin and albumin and cleared from
the circulatory system by hepatocytes (3). Hemoglobin and the
hemoglobin-haptoglobin, heme-hemopexin, and heme-albu-
min complexes can all be utilized by H. influenzae as heme
sources (48). We have recently shown that H. influenzae binds
hemoglobin directly at the cell surface, possibly as an initial
step in the utilization of hemoglobin-associated heme (14). We
have also demonstrated that both hemoglobin binding and the
binding of transferrin, an iron-binding glycoprotein which H.
influenzae uses as an iron source, are repressible by heme but
not by elemental iron alone (14, 34). In addition, we have
noted heme-repressible hemolytic activity expressed by H. in-
fluenzae (unpublished data), which may represent an important
first step in acquiring hemoglobin in vivo.
The objectives of the current study were to clone and to
characterize the gene(s) encoding the protein(s) mediating the
binding of hemoglobin by H. influenzae.
MATERIALS AND METHODS
Bacterial strains and growth conditions. H. influenzae type b and serologically
nontypeable strains (Table 1) were kindly provided by J. Musser, Baylor Uni-
versity, Houston, Tex., and have been described previously (34, 39). Strains of H.
influenzae serotypes a to f were obtained from the American Type Culture
Collection (ATCC). Strains of Haemophilus aphrophilus, Haemophilus parainflu-
enzae,Haemophilus haemolyticus, andHaemophilus parahaemolyticus were kindly
provided by J. Mortensen, St. Christopher’s Hospital for Children, Philadelphia,
Pa. Strains of Haemophilus segnis, Actinobacillus pleuropneumoniae, Gardnerella
vaginalis, and Branhamella catarrhalis were obtained from the ATCC. Strains of
Haemophilus, Actinobacillus, Gardnerella, and Branhamella spp. were routinely
maintained on brain heart infusion (BHI) agar (Difco, Detroit, Mich.) supple-
mented with 10 mg of both hemin and b-NAD per ml. For long-term storage,
strains were stored at 2708C in skim milk. For experiments in heme-replete
medium, H. influenzae was grown at 378C in BHI broth (Difco) supplemented
with 10 mg of b-NAD per ml and 10 mg of heme per ml (supplemented BHI;
sBHI). Heme-restricted growth of H. influenzae was performed in BHI supple-
mented with 10 mg of b-NAD per ml and 0.1 mg of hemin per ml (hemin-
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restricted BHI; hrBHI). Table 1 also shows the Escherichia coli strains which
were maintained on Luria-Bertani (LB) medium and supplemented with antibi-
otics, as appropriate, at the indicated concentrations. Plasmids used in these
studies and their relevant properties are also listed in Table 1.
Biotinylation of hemoglobin. Human hemoglobin (Sigma, St. Louis, Mo.) was
biotinylated as described previously (14). Hemoglobin (1 mg/ml) was dissolved in
phosphate-buffered saline (PBS) (pH 7.4), and NHS-LC [sulfosuccinimidyl-6-
(biotinamido) hexanoate] biotin (Pierce, Rockford, Ill.) was dissolved to a con-
centration of 1 mg/ml in water at 508C. To 5 ml of the hemoglobin solution was
added 430 ml of the biotin solution, and following incubation for 2 h at room
temperature, unbound biotin was removed by passage through a Sephadex G-15
column (Pharmacia, Piscataway, N.J.).
Preparation of outer membrane proteins. Outer membrane proteins were
isolated by selective solubilization with Triton X-100 essentially as previously
described (49). H. influenzae HI689 was grown to late logarithmic phase in sBHI
or hrBHI and harvested by centrifugation at 6,0003 g for 10 min. The cell pellets
were resuspended in distilled water to an optical density at 605 nm of 0.6, and 10
ml of the suspension was sonicated (Model CL4 with microtip, set to microtip
limit; Heat Systems, Farmingdale, N.Y.). Sonication was carried out in an ice-
NaCl bath for a total time of 2 min in 10-s bursts with 50 s between bursts. Triton
X-100 was added to the sonicate at a final concentration of 2% (vol/vol), and
following incubation for 5 min on ice, the mixture was sonicated as above or until
the solution was clear. The sonicate was centrifuged at 35,000 3 g for 1 h at 48C,
and the pellet was resuspended in 2 ml of 10 mM Tris-HCl (pH 7.4).
Affinity chromatography purification ofH. influenzae hemoglobin-binding pro-
tein (Hgp). Resuspended outer membranes, as described above, were divided
equally into two microcentrifuge tubes and 100 ml of biotinylated hemoglobin (1
mg/ml) was added. Following incubation for 1 h with gentle agitation, mixtures
were centrifuged at 13,000 3 g for 10 min. The pellet was resuspended in 1 ml
of buffer I (0.75% [wt/vol] Sarkosyl, 100 mM NaCl, 100 mM EDTA, 50 mM
Tris-HCl [pH 8.0]). The resuspended pellet was incubated for 1 h with 100 ml of
streptavidin-agarose (diluted 1:1 in sterile distilled water; Sigma). Samples were
centrifuged at 1,0003 g for 30 s and the supernatant was carefully removed. One
ml of buffer II (0.5% [wt/vol] Sarkosyl, 100 mM NaCl, 100 mM EDTA, 50 mM
Tris-HCl, [pH 8.0]) was added to the beads, and following incubation for 5 min
with gentle agitation, the mixture was centrifuged at 1,000 3 g and the super-
natant was removed. The beads were washed twice more in buffer II and once in
buffer III (100 mM NaCl, 50 mM Tris-HCl [pH 8.0]) as described above. All
incubations and washes were performed at room temperature. Following the
final wash the beads were resuspended in 20 ml of sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (50 mM Tris-
HCl [pH 6.8], 2% [vol/vol] 2-mercaptoethanol, 10% [vol/vol] glycerol, 1% [wt/
vol] SDS, 0.01% [wt/vol] bromophenol blue) and heated in a 1008C water bath
for 5 min to elute bound proteins. Eluted proteins were separated by SDS-PAGE
on 6.5% acrylamide gels by using the discontinuous buffer system of Laemmli
(25). Approximately 30 ml of protein preparation was loaded per lane.
N-terminal amino acid sequencing. Affinity chromatography-purified proteins
from heme-restricted H. influenzae HI689 were separated by SDS-PAGE on
7.5% acrylamide gels and transferred to membranes for N-terminal amino acid
sequencing as described by Moos (33). Thioglycolic acid (sodium salt) (0.066%
[wt/vol]) was added to the upper buffer reservoir during SDS-PAGE to remove
the by-products of acrylamide polymerization (33). Proteins were transferred in
a solution containing 10 mM 3-cyclohexylamino-1-propanesulfonic acid (CAPS)
(pH 10.5), 1% (vol/vol) methanol, and 0.05% (wt/vol) dithiothreitol to a polyvi-
nyldene difluoride membrane (Millipore, Bedford, Mass.) and visualized by
staining with 0.1% Coomassie blue in 50% (vol/vol) methanol. The entire mem-
brane was submitted to the UCLA Medical School Protein Microsequencing
Facility, where the N-terminal amino acid sequence of the 120-kDa protein was
determined.
DNA isolation. Bacterial genomic DNA was isolated by standard techniques as
previously described (44), or by using the DNA Now reagent (Biogentex, Sea-
brook, Tex.) as directed by the manufacturer. Plasmid DNA was isolated by the
use of Qiagen plasmid kits (Qiagen, Chatsworth, Calif.) as directed by the
manufacturer. DNA concentrations were assessed spectrophotometrically with a
Shimadzu UV-1201S Spectrophotometer with a DNA/Protein program pack
(Shimadzu, Kyoto, Japan).
Southern blot and DNA hybridization. DNA was digested with restriction
enzymes as directed by the manufacturers, separated on agarose gels (0.8%
[wt/vol] agarose) in TBE buffer (0.045 M Tris-borate, 0.001 M EDTA), and
transferred to Magnagraph nylon membranes (MSI, Westbrook, Mass.) by the
method of Southern as described by Sambrook et al. (44). For screening of
partial H. influenzae libraries in E. coli, bacterial colonies were transferred to a
Magnagraph nylon membrane and prepared for hybridization as described by
Sambrook et al. (44).
The enhanced chemiluminescence (ECL) 39-oligolabeling system (Amersham
Life Science, Arlington Heights, Ill.) was used as directed by the manufacturer to
label the 39 end of the oligonucleotides. The ECL random prime labeling kit
(Amersham) was used as directed by the manufacturer to label DNA probes.
Labeled oligonucleotides or DNA were used to probe Southern blots or colony
blots. For oligonucleotide probes, hybridization at 448C was followed by strin-
gency washes as follows: 53 SSC (13 SSC is 8.8 g of NaCl per liter plus 4.4 g of
sodium citrate per liter [pH 7.0])–0.1% (wt/vol) SDS twice for 5 min at room
temperature and 13 SSC–0.1% (wt/vol) SDS twice for 15 min at 448C. For DNA
probes the hybridization temperature was 608C and stringency washes were 13
SSC–0.1% (wt/vol) SDS for 15 min and 0.53 SSC–0.1% (wt/vol) SDS for 15 min
both at 608C. Hybridization was detected by using ECL nucleic acid detection
reagents (Amersham) as directed by the manufacturer. Blots were subsequently
exposed to X-ray film (Fuji Photo Film Co., Tokyo, Japan).
Cloning of the gene encoding Hgp. H. influenzae HI689 chromosomal DNA
was digested with EcoRI and separated on a 0.8% (wt/vol) agarose gel. Bands in
the region 4 to 6 kb were excised and purified from the gel by using the
Prep-A-Gene DNA purification kit (Bio-Rad, Hercules, Calif.) as directed by the
manufacturer. The isolated DNA fragments were ligated by standard techniques
to dephosphorylated EcoRI-digested pUC19 (44). The ligation mixture was
transformed into competent E. coli DH5a, and transformants were selected on
LB plates containing 50 mg of ampicillin per ml. Ampicillin-resistant colonies
were subcultured on selective media and colonies were probed with the N-
terminal oligonucleotides to identify positive clones. Putative positive plasmids
were isolated and confirmed by Southern blot and hybridization with the oligo-
nucleotide probes.
Partial automated sequencing (ABI model 373A; Recombinant DNA/Protein
Resource Facility, Oklahoma State University, Stillwater) of a positive clone
allowed us to identify a putative leader sequence and start codon and also a
presumed C-terminal sequence showing significant homology with other bacte-
rial iron- and heme-related proteins at the amino acid level. The length of DNA
flanked by the proposed start codon and C-terminal sequence would account for
a protein of approximately 120 kDa. Primers were designed for use in PCR to
allow for cloning of the putative coding region into a controlled expression
vector. Primers were synthesized (Molecular Biology Resource Facility, Univer-
sity of Oklahoma Health Sciences Center, Oklahoma City) with the sequences







689 Type b, ET 22 39
701 Type b, ET 90 39
1371 NT, ET 11 39
1373 NT, ET 13 39
1375 NT, ET 27 39
1378 NT, ET 31 39
1384 NT, ET 39 39
1389 NT, ET 44 39
1392 NT, ET 50 39
1397 NT, ET 57 39
1403 NT, ET 63 39
1412 NT, ET 72 39
1423 NT, ET 83 39
1429 NT, ET 93 39
9006 Type a ATCC
10211 Type b ATCC
9007 Type c ATCC
9008 Type d ATCC
8143 Type e ATCC
9833 Type f ATCC
Rd Capsule-deficient type d
E. coli
DH5a D(lacZYA-argF)U169 BRLb
BL21(DE3)pLysS F2, ompT, (DE3)pLysS, Cmr Novagen
JM109
Plasmids
pRSETA Ampr, carrying T7 promoter, metal
binding domain polylinker, F1
origin
Invitrogen
pHFJ1, pHFJ2 pUC19, carrying a 4.2-kb EcoRI
fragment from H. influenzae
This work
pXHGP pRSETA, carrying 3.2-kb PCR
product derived from pHFJ2.
This work
pHFJ.19 pUC19, carrying a 1.9-kb BglII frag-
ment from pHFJ2
This work
a NT, nontypeable; ET, multilocus enzyme electrophoretic type; F2, F epi-
some negative; Ampr, ampicillin resistance (50 mg/ml); Cmr, chloramphenicol
resistance (50 mg/ml).
b BRL, Bethesda Research Laboratories.
VOL. 64, 1996 HEMOGLOBIN BINDING BY HAEMOPHILUS INFLUENZAE 3135
59-GACCAGGGATCCATGACCAATTTTAG-39 and 59-GGAAGGGGTACC
CTAGAATTCAAACTG-39. A BamHI site upstream of the start codon and a
KpnI site downstream of the stop codon were included in the primers to allow for
directional cloning of the PCR product in the vector pRSETA in the correct
reading frame. PCR was performed in 50-ml reactions with 30 ng of pHFJ2,
linearized by digestion with HindIII, as template. PCRs contained 2 mM MgCl2,
200 mM each deoxynucleoside triphosphate, 100 ng of each primer and 2 U of
Taq DNA polymerase. PCR was carried out for 30 cycles with each cycle con-
sisting of denaturation at 958C for 1 min, annealing at 558C for 1 min, and primer
extension at 728C for 3.5 min, with a final extension time of 10 min. Amplicons
of the expected size (3.2 kb) were gel purified and mapped by digestion with
BglII. The PCR products were digested with BamHI and KpnI, and ligated to
gel-purified BamHI- and KpnI-digested pRSETA. The ligation mixture was
transformed into E. coli BL21(DE3)pLysS and recombinants were selected on
LB agar containing 50 mg of ampicillin per ml. Plasmids were isolated from
ampicillin-resistant colonies and mapped by restriction enzyme digestion to iden-
tify clones containing the expected product. A positive clone was identified and
designated pXHGP.
Expression of Hgp in E. coli. A hemoglobin-binding dot blot assay was used to
determine whether E. coli containing pXHGP bound hemoglobin. Recombinant
E. coli BL21(DE3)pLysS was grown to mid-logarithmic phase in LB medium
with appropriate antibiotic supplementation. After induction with 1 mM isopro-
pyl b-D-thiogalactopyranoside (IPTG) for 4 h, cells were harvested and resus-
pended in PBS to a concentration of 108 CFU/ml. In a dot blot manifold
(Bio-Rad), 100 ml of cell suspension (107 CFU) was filtered onto nitrocellulose
membranes. Membranes were air dried for 15 min and then incubated in 10%
(wt/vol) skim milk in PBS for 1 h. Membranes were incubated in 500 ng of
biotinylated human hemoglobin per ml in PBS for 1 h, and then washed three
times for 10 min each in PBS. A second blocking step in 10% (wt/vol) skim milk
in PBS was performed for 1 h; this was followed by incubation in 25 ng of
streptavidin-horseradish peroxidase conjugate (Jackson Immunoresearch, West
Grove, Pa.) per ml in PBS for 1 h. Membranes were washed three times for 10
min each in PBS and developed with ECL Western blot (immunoblot) detection
reagents (Amersham) as directed by the manufacturer. All steps were performed
at room temperature.
In some experiments bacteria were harvested and resuspended to 108 CFU/ml
and 5-ml samples were sonicated (Model CL4 with microtip, set to microtip limit;
Heat Systems). Sonication was carried out in an ice-NaCl bath for a total time of
2 min in 10-s bursts with 50 s between bursts. Sonicates (100 ml) were filtered
onto nitrocellulose membranes in a dot blot manifold and the membranes were
probed and developed as above.
Western immunoblot analysis. The 100-kDa hemoglobin-binding protein of
Haemophilus ducreyi 35000 was affinity purified as previously described (9).
Recombinant protein from IPTG-induced BL21(DE3)pLysS harboring pXHGP
was purified by using the Xpress protein purification system (Invitrogen) as
directed by the manufacturer. These proteins and the affinity-purified 120-kDa
protein from H. influenzae HI689 were separated by SDS-PAGE on 7.5% acryl-
amide gels and electrophoretically transferred to nitrocellulose membranes.
Membranes were blocked in 1% (wt/vol) skim milk in PBS for 1 h and then
probed with a 1:1,000 dilution in PBS containing 1% (wt/vol) skim milk of an
antibody raised against the 100-kDa HgbA of H. ducreyi in rabbits (9). Following
four washes in PBS for 15 min each, membranes were probed with 1:10,000
donkey anti-rabbit immunoglobulin-horseradish peroxidase conjugate (Amer-
sham) in PBS with 1% (wt/vol) skim milk. Membranes were washed four times
for 15 min each in PBS and developed by using ECL detection reagents as
directed by the manufacturer.
RESULTS
Affinity purification of Hgp.H. influenzae is heme dependent
and utilizes hemoglobin as a heme source in vitro (48). Using
a whole cell dot blot assay, we have previously shown that
hemoglobin binds to the H. influenzae cell surface in a manner
indicative of a specific receptor, and we have demonstrated
that binding is induced by limiting heme levels in the growth
medium (14). To further investigate the possibility that hemo-
globin binding to H. influenzae is mediated through an outer
membrane protein regulated by heme levels, we subjected re-
suspended outer membrane proteins of strain HI689 to affinity
purification with biotinylated hemoglobin. A 120-kDa protein
was isolated from outer membranes derived from strain HI689
grown under heme-restricted conditions (hrBHI) (Fig. 1, lane
C) but not from outer membrane proteins derived from HI689
grown under heme-replete conditions (sBHI) (Fig. 1, lane B).
N-terminal amino acid sequencing. An N-terminal amino
acid sequence of the affinity-purified Hgp was obtained from
affinity-purified outer membranes of H. influenzae HI689. The
determined N-terminal amino acid sequence was AQPTNQPT
NQ. The synthetic oligonucleotides 59-CAACCAACTAATCA
ACCAAC-39 and 59-CAGCCTACAAATCAACCAAC-39, syn-
thesized by RansomHill Bioscience, Inc., Ramona, Calif., were
designed on the basis of the N-terminal amino acid sequence
of the 120-kDa Hgp after consulting the H. influenzae codon
preference data of Gilsdorf et al. (15). These two oligonucle-
otides were used in a mixture to probe Southern blots of H.
influenzae HI689 genomic DNA digests. The oligonucleotides
hybridized to an approximately 4.2-kb EcoRI fragment (Fig. 2,
lane B) which was deemed of appropriate size for cloning. No
hybridization of the oligonucleotides to either E. coli chromo-
somal DNA (data not shown) or pUC19 (Fig. 2, lane C) was
detected, suggesting that the oligonucleotides could be used to
identify recombinant clones containing the structural gene en-
coding the 120-kDa protein.
Cloning of the DNA fragment encoding Hgp. A limited
genomic library of H. influenzae HI689 was constructed in the
vector pUC19 as described in Materials and Methods. Two
recombinant clones were isolated from this library by using the
N-terminal amino acid sequence-derived oligonucleotides as
probes. Both clones contained inserts of approximately 4.2 kb
which hybridized in Southern analyses with the oligonucleotide
probes (Fig. 2, lanes D and F). These plasmids were designated
pHFJ1 and pHFJ2. Partial mapping of the two clones revealed
them to contain the same fragment in reverse orientation (Fig.
3). From preliminary sequencing analysis, the N-terminal nu-
cleotide sequence and a putative C-terminal sequence flanking
a region of the correct size to encode a 120-kDa protein were
identified. The N-terminal and C-terminal regions showed sig-
nificant homology at the amino acid level with other bacterial
iron- and heme-related proteins (Fig. 4 and 5), and a predicted
leader peptide of 23 amino acids was identified (Fig. 4). On the
basis of the sequence data, primers were designed to amplify
the entire putative coding region by PCR. Restriction enzyme
sites were included in the primers to permit directional cloning
in the expression vector pRSETA. By using pHFJ2 as the
template in the PCR, an approximately 3.2-kb product was
FIG. 1. Identification of the 120-kDa Hgp in H. influenzae. An SDS-PAGE
(6.5% acrylamide) gel stained with Coomassie blue is shown. Lane A, molecular
mass marker; lane B, affinity-purified outer membrane protein fromH. influenzae
type b grown in sBHI; lane C, affinity-purified outer membrane protein from H.
influenzae type b grown in hrBHI. Numbers at left are molecular masses.
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amplified; restriction analysis of the amplicon revealed it to be
the expected product. The gel-purified PCR product was suc-
cessfully cloned into pRSETA, as demonstrated by restriction
mapping (Fig. 3), and the resulting plasmid was designated
pXHGP.
Expression of Hgp in E. coli. A hemoglobin-binding dot blot
assay was used to investigate whether the cloned hemoglobin-
binding protein gene in E. coli resulted in expression of a hemo-
globin-binding phenotype. Sonicated E. coli BL21(DE3)pLysS
harboring pXHGP bound biotinylated human hemoglobin fol-
lowing induction with IPTG (Fig. 6, row D). Whole cells of
IPTG-induced E. coli BL21(DE3)pLysS harboring pXHGP
did not bind hemoglobin (Fig. 6, row B), probably because the
recombinant protein is not expressed at the E. coli cell surface.
E. coli BL21(DE3)pLysS harboring pRSETA alone and in-
duced with IPTG did not bind hemoglobin, whether or not the
cells were lysed by sonication (Fig. 6, rows A and C), and all
tested strains were unable to bind hemoglobin when uninduced
(data not shown). These data demonstrate that pXHGP con-
tained a fragment of DNA from H. influenzae HI689 which
encodes the protein Hgp, which is expressed in E. coli.
Distribution of hgp. Samples of genomic DNA (1 mg) from
a number of H. influenzae strains and other bacterial species
were digested with EcoRI, separated on agarose gels, blotted
to nylon membranes, and probed with a labeled 1.9-kb BglII
fragment internal to the putative hgb gene (Fig. 3). The labeled
insert hybridized strongly with a band of approximately 4.2 kb
in H. influenzae strains of types a, b, and c, and in seven
nontypeable strains (Table 2). The labeled insert also hybrid-
ized with H. influenzae strains of types d, e, and f and also with
five nontypeable strains, although the hybridization pattern
was variable (Table 2). No hybridization was seen with either
H. influenzae Rd or any other tested species (Table 2). These
data indicate that the 120-kDa Hgp may be widely distributed
across the species H. influenzae.
Lack of cross-reactivity between HgbA of H. ducreyi and Hgp
of H. influenzae. A conserved 100-kDa hemoglobin-binding
protein from H. ducreyi, HgbA, has been recently identified by
Elkins (8, 9). To determine if antibodies generated against
HgbA would recognize the 120-kDa Hgp described in this pa-
per, Western blots were probed with antibodies raised against
the 100-kDa hemoglobin-binding protein of H. ducreyi. The
antibodies reacted with the 100-kDa protein isolated from
H. ducreyi but not with either the 120-kDa protein isolated
from H. influenzae or the recombinant protein isolated from
IPTG-induced E. coli (data not shown).
FIG. 2. Southern blot probed with ECL-labeled oligonucleotide specific for
the 120-kDa Hgp N terminus and developed with ECL detection reagents as
directed by the manufacturer (Amersham). Lane A, labeled lHindIII fragments;
lane B, H. influenzae HI689 chromosomal DNA EcoRI digest; lane C, EcoRI-
digested pUC19; lane D, EcoRI-digested pHFJ1; lane E, undigested pHFJ1; lane
F, EcoRI-digested pHFJ2; lane G, undigested pHFJ2. Arrow indicates 4.2-kb
hybridizing bands.
FIG. 3. Partial restriction enzyme maps of the 4.2-kb insert of pHFJ2, the
predicted ORF encoding Hgp, and pHFJ.19. The boxed area represents the
putative ORF encoding Hgp and the insert of pXHGP. Numbers are sizes in
kilobase pairs.
FIG. 4. Peptide alignments between the N-terminal region of the putative
Hgp and the N-terminal regions of the following iron- and heme-related pro-
teins: HgbA, a hemoglobin-binding protein of H. ducreyi (9); HmbR, a hemo-
globin-binding protein of N. meningitidis (47); Tbp1-Hi, a transferrin-binding
protein of H. influenzae (16); and Tbp1-Nm, a transferrin-binding protein of
N. meningitidis (29). The 2 indicates the proposed leader peptide cleavage site
of Hgp.
FIG. 5. Peptide alignments between the C-terminal region of the putative
Hgp and the C-terminal regions of the following iron- and heme-related pro-
teins: HgpA, a hemoglobin-binding protein of H. ducreyi (9); HmbR, a hemo-
globin-binding protein of N. meningitidis (47); Tbp1-Hi, a transferrin-binding
protein of H. influenzae (16); and Tbp1-Nm, a transferrin-binding protein of
N. meningitidis (29).
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DISCUSSION
H. influenzae has an absolute growth requirement for pro-
toporphyrin IX, the immediate precursor of heme (11). The
availability of heme within the human host to invading patho-
gens is strictly limited. Heme is contained largely within intra-
cellular hemoglobin; free hemoglobin and heme are rapidly
bound by the serum proteins haptoglobin (in the case of he-
moglobin) and hemopexin or albumin (in the case of heme)
and cleared from the circulation (3). The heme requirement of
H. influenzae can be satisfied in vitro by hemoglobin, hemo-
globin complexed to haptoglobin, heme complexed to either
hemopexin or albumin, or protoporphyrin IX in the presence
of an iron source such as ferritransferrin (3, 35, 36). The
mechanism(s) by which H. influenzae takes up iron and/or
heme from these protein sources has not been fully elucidated.
It is clear, however, that H. influenzae does not produce sid-
erophores (7, 35, 36, 41). Certain uptake mechanisms involve a
direct interaction between the protein and the bacterial cell
surface (14, 36, 55). The utilization of heme and the acquisition
of heme from hemoglobin, the hemoglobin-haptoglobin com-
plex, and the heme-hemopexin complex are dependent on a
functional tonB gene, indicating that uptake is mediated by an
outer membrane TonB-dependent protein(s) (23, 42); a tonB
homolog has been reported in the recently sequenced genome
ofH. influenzaeRd (13). On the basis of the sequence currently
available, Hgb exhibits significant homology with other TonB
proteins over regions that are highly conserved among this
class of proteins (6). In the case of acquisition of iron from
transferrin, two outer membrane proteins, Tbp1 and Tbp2, are
involved in binding of transferrin to H. influenzae (16). Subse-
quent steps in the process have not been fully elucidated,
although there is evidence for a periplasmic iron transport
system encoded by an operon of three genes hitABC (1). Pro-
teins binding the heme-hemopexin complex have been de-
scribed, one of which is apparently secreted into the growth
medium (4, 5, 20, 56). A heme-binding outer membrane pro-
tein has been isolated (27), and a heme-binding lipoprotein
with significant homology to a periplasmic transport protein of
E. coli has also been characterized (19, 21).
In this report we identify the gene encoding a 120-kDa
protein of H. influenzae type b. Hgp was isolated from
H. influenzae by using affinity chromatography and an N-ter-
minal amino acid sequence was obtained (AQPTNQPTNQ).
By using oligonucleotides derived from the N-terminal se-
quence as probes, a DNA fragment from H. influenzae was
cloned to yield pHFJ2. Partial sequencing of pHFJ2 revealed
that the N-terminal nucleotide sequence would encode a pep-
tide of sequence AEPTNQPTNQ. On the basis of sequence
homology and Southern analysis, there is no gene correspond-
ing to hgp present in the Rd chromosomal sequence recently
reported. Although pHFJ2 contains a region of greater than
95% identity to the arcB locus ofH. influenzae upstream of hgp,
there is no sequence homologous to hgp downstream of the
arcB locus in the Rd chromosomal sequence (13). However,
the nucleotide sequence encoding the N-terminal region of
Hgp is highly homologous with the N-terminal regions of the
putative products of 3 separate open reading frames (ORFs) in
the Rd chromosomal sequence (13). Each of these areas in the
Rd sequence (designated HI0661, HI0712, and HI1566 by
Fleischmann et al. [13]) and the corresponding region of hgp
contains multiple ccaa repeats, with the number of repeats
varying between 18 and 36, giving rise to proteins with 6 to 12
PTNQ repeats. In two of the three putative ORFs in Rd, the
FIG. 6. Dot blot analysis of human hemoglobin binding to E. coli either
harboring or without pXHGP. Columns 1, 2, and 3 represent serial dilutions of
whole cells or sonicated cells (see Materials and Methods). Row A, whole cells
ofE. coliBL21(DE3)pLysS pRSETA; rowB, whole cells ofE. coliBL21(DE3)pLysS
pXHGP; row C, sonicates ofE. coliBL21(DE3)pLysS pRSETA; rowD, sonicates of
E. coli BL21(DE3)pLysS pXHGP.
TABLE 2. Hybridization with the 1.9-kb insert of pHFJ.19
Strain and/or typea Hybridization Band size
H. influenzae
ATCC 9006, type a 1 4.2
ATCC 10211, type b 1 4.2
ATCC 9007, type c 1 4.2
ATCC 9008, type d 1 .10
ATCC 8143, type e 1 6.4
ATCC 9833, type f 1 9.0
701, type b 1 6.4
1371, NT 1 4.2
1373, NT 1 4.2
1375, NT 1 6.4
1378, NT 1 .10
1384, NT 1 4.2
1389, NT 1 4.2
1392, NT 1 4.2
1397, NT 1 6.4
1403, NT 1 9.0
1412, NT 1 4.2
1423, NT 1 .10
1429, NT 1 4.2
Rd 2 NAb
H. parainfluenzae 203 2 NA
H. aphrophilus ATCC 33389 2 NA




H. haemolyticus 97 2 NA
H. segnis ATCC 33393 2 NA
A. pleuropneumoniae
ATCC 27088 2 NA
ATCC 27089 2 NA
G. vaginalis ATCC 14018 2 NA
B. catarrhalis ATCC 8176 2 NA
E. coli JM109 2 NA
a NT, nontypeable.
b NA, not applicable.
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ccaa repeat is followed by an in-frame stop codon, while the
third constitutes an ORF of approximately 3 kb. The function
of the repeat region is not known, although since conservation
is 100% at the nucleotide level, it seems likely that its impor-
tance lies in the ccaa unit rather than in the encoded peptide
sequence. It is possible that the ccaa repeats may have a reg-
ulatory function, perhaps in a manner analogous to the slip-
strand regulation involved in phase variation of lipopolysac-
charide expression in H. influenzae (50). In the two ORFs
identified in Rd which have a stop codon downstream of the
ccaa region, slippage across one ccaa unit would eliminate the
stop codon. The N-terminal and C-terminal amino acid se-
quences of Hgp have been compared with the correspond-
ing amino acid regions of the proteins encoded by HI0661,
HI0712, and HI1566. To facilitate this, the reading frames of
HI0661 and HI1566 were altered by addition or removal of a
ccaa unit from the published nucleotide sequence as appropri-
ate. Over the 76 amino acids directly subsequent to the final
PTNQ unit of Hgp, identity was calculated as 80% with
HI0661, 70% with HI0712, and 72% with HI1566. Over the 90
amino acids at the C-terminal of Hgp, the respective identities
were 73% (HI0661), 63% (HI0712), and 62% (HI1566). These
analyses indicate that the protein encoded by ORF HI0661 is
the most closely related to Hgp. The ORF HI0661 does not
correspond to hgp since we have partially cloned a homolog of
HI0661 fromH. influenzaeHI689 (data not shown). In addition
we have partially cloned HI0712 from HI689 (data not shown).
The discrepancy between the microsequencing-derived N-
terminal sequence (AQPTNQPTNQ) and the nucleotide se-
quence-derived N-terminal sequence (AEPTNQPTNQ) is un-
likely to be due to microsequencing errors since the misread of
a glutamine (Q) for a glutamic acid (E) is highly unlikely (13a,
24a). The possibility of nucleotide sequencing errors was min-
imized by repeated sequencing across the area of interest. An
alternative explanation for the difference is that the protein
originally isolated by affinity chromatography was not Hgp, but
rather one of the three ORF products identified in H. influen-
zae Rd. In particular, the product of HI0712 has a predicted
molecular mass of 124 kDa, compared with approximately 120
kDa for Hgp, and the nucleotide sequence-derived N-terminal
amino acid sequence of HI0712 is AQPTNQPTN. The product
of HI0661 has a predicted molecular mass of 115 kDa and an
N-terminal amino acid sequence of AQPTNQPTN, while the
data for the HI1566 gene product would be 114 kDa and
AEPTNQPTN, respectively. Thus, it is possible that an alter-
nate gene product was originally isolated (i.e., ORF HI0712 or
ORF HI0661), while the oligonucleotides designed from the
amino acid sequence led to cloning of hgp on the basis of the
100% conservation of the ccaa region. This possibility indicates
that there is more than one hemoglobin-binding protein ex-
pressed by H. influenzae, and that one (or more) of HI0661,
HI0712, or HI1566 may represent this additional protein(s).
Work is under way to clarify how many hemoglobin-binding
proteins H. influenzae expresses and to define the functions of
the gene products of HI0661, HI0712, and HI1566.
A putative coding sequence from pHFJ2 was subcloned into
E. coli, and expression of this gene resulted in the recombinant
strain binding hemoglobin. Hemoglobin-binding proteins have
been reported in H. ducreyi and Neisseria meningitidis (8, 28,
30, 47). Using affinity chromatography, Elkins isolated a pro-
tein of 100 kDa fromH. ducreyi, and also reported the isolation
of an approximately 115-kDa protein from H. influenzae DL42
(8, 9). The 115-kDa protein from H. influenzae was not recog-
nized by antibodies raised to either the entire H. ducreyi 100-
kDa protein or to the N-terminal peptide of the 100-kDa
protein. In addition, the N-terminal sequence reported for the
H. ducreyi protein (ESNMQTEKLETIVV) is highly dissimi-
lar to the N-terminal of the 120-kDa protein reported here
(AEPTNQPTNQ). Neither the recombinant Hgp nor the wild-
type Hgp reacts with an antibody raised against the 100-kDa
protein of H. ducreyi; however, it remains to be clarified
whether Hgp is related to the 115-kDa protein isolated fromH.
influenzae DL42 (9). Two hemoglobin-binding proteins have
been described in N. meningitidis, one of 85 kDa (30) and a
second of 89.5 kDa (47); the former binds the hemoglobin-
haptoglobin complex. These two proteins were isolated from
different strains and it is not known whether both proteins are
expressed in the same strain or whether they interact with each
other in the acquisition of heme from hemoglobin, although
Lee and Hill have suggested that meningococcus possesses two
hemoglobin receptors with different affinities for the ligand
(28). In the case of transferrin binding by H. influenzae and N.
gonorrhoeae, it is clear that expression of both Tbp1 and Tbp2
is necessary for maximal binding of the ligand (2, 16), although
partial binding occurs when either protein is present alone.
There is no direct evidence to date for the existence of more
than one hemoglobin-binding protein in either H. influenzae or
H. ducreyi. In previous studies (14), we showed that binding of
hemoglobin by H. influenzae was blocked by the hemoglobin-
haptoglobin complex. It is possible that, similarly to the 85-kDa
N. meningitidis protein (30), Hgp also binds the hemoglobin-
haptoglobin complex, and studies will be performed to answer
this question.
Hgp was isolated from heme-restricted but not from heme-
replete H. influenzae, indicating that expression of the protein
may be regulated by levels of heme. Previously, we have shown
that the hemoglobin-binding phenotype in H. influenzae is re-
pressible by heme (14) and that transferrin binding expressed
byH. influenzae is repressible by heme as opposed to elemental
iron levels (34). The 100-kDa hemoglobin-binding protein of
H. ducreyi and the 39.5-kDa heme-binding outer membrane
protein of H. influenzae are similarly repressible by heme,
rather than by elemental iron (8, 9, 27). In many bacterial
species the Fur (ferric uptake regulator) protein is a regulatory
element which in the presence of iron binds to a conserved
binding sequence (the Fur box) upstream of iron-regulated
genes, preventing transcription (31). Sequences homologous to
the consensus Fur binding sequence (31) have been reported
upstream of the H. ducreyi hemoglobin-binding protein (9), the
H. influenzae transferrin-binding proteins (16), and a heme-
hemopexin utilization gene cluster of H. influenzae (5). In none
of these cases has the putative Fur binding site been shown to
be functional; indeed the 100-kDa heme-hemopexin-binding
protein described by Cope et al. appears to be expressed con-
stitutively (5). That this protein is expressed in a medium which
is sufficient in heme and iron, despite a putative Fur box (5),
raises further questions regarding the functionality of this pu-
tative Fur box. Fleischmann et al. have recently identified an
ORF with strong homology (61.4% identity; 75% similarity) to
the E. coli fur gene in the genome of H. influenzae Rd (13, 45).
Thus, a Fur analog may be a regulatory factor for expression of
the H. influenzae iron- and heme-related proteins, although it
is clear that clarification is necessary. In addition, the 57-kDa
heme-hemopexin-binding protein identified by Wong et al. is
apparently repressible by iron (55, 56), although the heme-
hemopexin phenotype is variously reported as being inducible
by iron-restricted growth or heme-restricted anaerobic growth
(21, 55). The regulation of heme- and iron-related proteins in
H. influenzae remains poorly characterized, and further studies
should be undertaken to clarify the roles of iron and heme in
regulating their expression.
The gene encoding the 120-kDa Hgp appears to be widely
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distributed among the species of H. influenzae. Of 19 H. influ-
enzae strains tested, 10 had a strongly hybridizing band at
approximately 4.2 kb. Eight of the remaining nine strains ex-
hibited varying hybridization patterns (Table 2), while strain
Rd did not hybridize at all. No other tested species hybridized
with the 1.9-kb probe. H. influenzae type b 701 represents a
highly divergent type b strain (39), previously reported to lack
expression of hemoglobin binding (14). The hybridizing band
in this strain was approximately 6.4 kb, and this may represent
the gene encoding Hgp or, alternatively, a related protein of
different function. A number of H. influenzae strains, including
strain 701, that have been reported to lack transferrin binding
activity (22, 34) were subsequently shown to both possess the
genes encoding Tbp1 and Tbp2 and to express transferrin
binding under different growth conditions (17). It is possible
that strain 701 would similarly express hemoglobin binding if
grown under appropriate conditions. The failure of hgb to
hybridize with H. haemolyticus is interesting since we have
shown hemoglobin binding to this organism (14), and it is thus
likely that H. haemolyticus strains possess an unrelated hemo-
globin-binding protein.
In conclusion we have identified a 120-kDa Hgp of H. influ-
enzae, the expression of which is repressible by heme, and we
have cloned the gene encoding Hgp. We speculate that Hgp
represents an important step in the acquisition of heme from
hemoglobin. Further studies will clarify the role of Hgp in
hemoglobin utilization, investigate the possible existence of
other hemoglobin-binding proteins, and define the mechanism
of regulation of this protein(s).
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